Krystal Biotech ($KRYS) Insider Trading & Smart Money Activity

Krystal Biotech, Inc. · Biotechnology · Latest filing Jun 25, 2026

Krystal Biotech, Inc. ($KRYS) has 2 insider trades and 3 analyst ratings on file. Insiders filed 2 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

0

Net insider $ (12 mo)

$0

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

3

KRYS insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	0	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All KRYS insider, congress, 13F and analyst activity

All Insiders Analysts

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Jun 25, 2026	Insider	Thomas John CharlesEVP, General Counsel	Sell (Option exercise)	1K sh			+4.2%	-2.3%			—
Jun 25, 2026	Insider	Thomas John CharlesEVP, General Counsel	Buy (Option exercise)	1K sh	$179.25K		+4.2%	-2.3%			—
Jun 18, 2026	Analyst	TD Cowen	Reiterates to buy		PT $403		+3.4%	-2.5%			Read
Jun 16, 2026	Analyst	HC Wainwright	Reiterates to buy		PT $361		+5.2%	+5.7%			Read
Jun 16, 2026	Analyst	HC Wainwright	Reiterates to buy		PT $361		+5.2%	+5.7%			Read

1W / 1M / 6M = how KRYS moved from the trade or filing date.

Insider trading in KRYS: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
Thomas John Charles	EVP, General Counsel	2	—		Jun 25, 2026

Analyst ratings on KRYS

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 18, 2026	TD Cowen	Reiterates	buy	$403	+3.4%	-2.5%		Read
Jun 16, 2026	HC Wainwright	Reiterates	buy	$361	+5.2%	+5.7%		Read
Jun 16, 2026	HC Wainwright	Reiterates	buy	$361	+5.2%	+5.7%		Read

Frequently asked questions

What is the latest insider trade in KRYS?

Thomas John Charles, EVP, General Counsel filed a sell (option exercise) of 1K sh on Jun 25, 2026.

Other biotechnology stocks

• $NUVL
• $ARWR
• $KYMR
• $APGE
• $PTGX
• $IBRX
• $CRNX
• $AXSM

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.